thioguanine-anhydrous and Kidney-Neoplasms

thioguanine-anhydrous has been researched along with Kidney-Neoplasms* in 4 studies

Trials

1 trial(s) available for thioguanine-anhydrous and Kidney-Neoplasms

ArticleYear
Phase II trial of 6-thioguanine in advanced renal cell carcinoma. An Illinois Cancer Center study.
    Investigational new drugs, 1994, Volume: 12, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Thioguanine

1994

Other Studies

3 other study(ies) available for thioguanine-anhydrous and Kidney-Neoplasms

ArticleYear
Low-dose CT protocols for guiding radiofrequency ablation for the treatment of small renal cell carcinomas.
    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2018, Volume: 34, Issue:6

    Computed tomography (CT)-guided radiofrequency ablation (RFA) results in a high radiation dose. This study aimed to assess low-dose CT protocols for guiding RFA and oncologic outcomes for the treatment of small renal cell carcinoma (RCC).. Between December 2011 and December 2014, CT-guided RFA was performed in 31 patients with 31 biopsy-proven RCCs (median, 2.1 cm). RFA included planning, targeting, monitoring and survey phases. The dose length product (DLP), CT dose index volume (CTDIvol), effective dose, number of scans, scan range, tube current and exposure time of RFA phases were compared. The 3-year recurrence-free survival rate was recorded. Nonparametric or parametric repeated-measures ANOVA with Dunn's or Tukey-Kramer multiple comparisons and Kaplan-Meier analysis were used for statistical analysis.. The median total DLP, CTDIvol and effective dose of CT-guided RFA procedures per session were 1238.8 mGy (range 517.4-3391.7 mGy), 259.7 mGy (10.7-67.9 mGy) and 18.6 mSv (7.8-50.9 mSv), respectively. The median DLP, CTDIvol, effective dose, number of scans, tube current and exposure time during the targeting phase were higher than those during the other phases (p < 0.001). The scan range in the targeting phase was the same as that in the monitoring phase (p > 0.05) but smaller than those in the planning and survey phases (p < 0.001). The 3-year recurrence-free survival rate was 96.7%.. Low-dose CT protocols for guiding RFA may reduce radiation dose without compromising oncologic outcomes. Reducing the number of scans during the targeting phase contributes to dose reduction.

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cytarabine; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Radiofrequency Ablation; Retrospective Studies; Thioguanine; Treatment Outcome

2018
Somatic mutations are frequent and increase with age in human kidney epithelial cells.
    Human molecular genetics, 1996, Volume: 5, Issue:2

    We have used a primary cloning assay to determine the frequency of 6-thioguanine (TG)-resistant tubular epithelial cells in kidney tissue from 72 human donors ranging in age from 2 to 94 years. The frequency of TG-resistant mutants ranged from approximately 5 x 10(-5) for donors in the first decade of life to approximately 2.5 x 10(-4) for donors in the eighth and later decades of life. Two different statistical analyses indicated that this increase in mutant frequency is exponential with age. We also observed a 2-fold higher TG-resistant mutant frequency in nephrectomy kidneys containing a coincident renal carcinoma. DNA sequence analyses revealed HPRT gene mutations in each of 14 TG-resistant mutants from seven unrelated donors. Thirteen of these 14 mutants resulted from independent mutational events. These results suggest that somatic mutations are common in renal--and perhaps in other human--epithelia, and thus could play an important role in the genesis of age-associated disease.

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Base Sequence; Carcinoma; Cells, Cultured; Child; Child, Preschool; DNA Primers; Epithelium; Humans; Hypoxanthine Phosphoribosyltransferase; Kidney; Kidney Cortex; Kidney Neoplasms; Middle Aged; Molecular Sequence Data; Mutation; Nephrectomy; Thioguanine

1996
[Renal cell carcinoma and bladder tumor observed in the Automated Multiphasic Health Testing and Services of Tokai University Hospital].
    Hinyokika kiyo. Acta urologica Japonica, 1985, Volume: 31, Issue:8

    From June 1975 through December 1983, 48,604 individuals consisting of 34,535 males and 14,069 females underwent health examinations at the Automated Multiphasic Health Testing and Services (AMHTS) Center in Tokai University Hospital. There were five patients with renal cell carcinoma and three with bladder cancer. We reviewed the clinical courses of these patients and discussed the early detection of urological cancers in AMHTS. Patients with renal cell carcinoma were brought to the urology department with various findings in AMHTS. A 44-year-old male was referred to us for the investigation of multiple metastatic shadows in the chest X-P and left renal tumor was diagnosed by intravenous pyelography (IVP) and computed tomography (CT). Renal tumor of a 57-year-old male was diagnosed by the investigations of abnormal renal calcifications found in AMHTS. A 39-year-old female had undergone health check-ups several times but was not found to have a renal tumor. The diagnosis of left renal tumor was made by the abdominal CT carried out after the operation on cerebellar hemangioblastoma. The fourth patient was a 60-year-old female with microscopic hematuria found in AMHTS and the diagnosis was confirmed by calyceal deformity shown in IVP. The last patient was a 64-year-old male and was accidentally demonstrated to have a right renal mass by ultrasonography when he was reexamined for the hepatic abnormality found in AMHTS. He showed microscopic hematuria in the AMHTS urinalysis. The diagnosis was confirmed by IVP, CT and renal angiography.(ABSTRACT TRUNCATED AT 250 WORDS)

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cytarabine; Female; Hospitals, University; Humans; Japan; Kidney Neoplasms; Male; Middle Aged; Multiphasic Screening; Thioguanine; Ultrasonography; Urinary Bladder Neoplasms

1985